147 related articles for article (PubMed ID: 28256220)
1. Do All X-ray Structures of Protein-Ligand Complexes Represent Functional States? EPOR, a Case Study.
Corbett MSP; Mark AE; Poger D
Biophys J; 2017 Feb; 112(4):595-604. PubMed ID: 28256220
[TBL] [Abstract][Full Text] [Related]
2. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation.
Livnah O; Stura EA; Middleton SA; Johnson DL; Jolliffe LK; Wilson IA
Science; 1999 Feb; 283(5404):987-90. PubMed ID: 9974392
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Asymmetry of Activated EPO Receptor Enables Designing Small Molecule Agonists.
Guarnieri F
Vitam Horm; 2017; 105():19-37. PubMed ID: 28629518
[TBL] [Abstract][Full Text] [Related]
4. Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands.
Moraga I; Wernig G; Wilmes S; Gryshkova V; Richter CP; Hong WJ; Sinha R; Guo F; Fabionar H; Wehrman TS; Krutzik P; Demharter S; Plo I; Weissman IL; Minary P; Majeti R; Constantinescu SN; Piehler J; Garcia KC
Cell; 2015 Mar; 160(6):1196-208. PubMed ID: 25728669
[TBL] [Abstract][Full Text] [Related]
5. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation.
Livnah O; Johnson DL; Stura EA; Farrell FX; Barbone FP; You Y; Liu KD; Goldsmith MA; He W; Krause CD; Pestka S; Jolliffe LK; Wilson IA
Nat Struct Biol; 1998 Nov; 5(11):993-1004. PubMed ID: 9808045
[TBL] [Abstract][Full Text] [Related]
6. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain.
Constantinescu SN; Keren T; Socolovsky M; Nam H; Henis YI; Lodish HF
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4379-84. PubMed ID: 11296286
[TBL] [Abstract][Full Text] [Related]
7. Active conformation of the erythropoietin receptor: random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains.
Lu X; Gross AW; Lodish HF
J Biol Chem; 2006 Mar; 281(11):7002-11. PubMed ID: 16414957
[TBL] [Abstract][Full Text] [Related]
8. Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide.
Middleton SA; Barbone FP; Johnson DL; Thurmond RL; You Y; McMahon FJ; Jin R; Livnah O; Tullai J; Farrell FX; Goldsmith MA; Wilson IA; Jolliffe LK
J Biol Chem; 1999 May; 274(20):14163-9. PubMed ID: 10318834
[TBL] [Abstract][Full Text] [Related]
9. Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer.
Seubert N; Royer Y; Staerk J; Kubatzky KF; Moucadel V; Krishnakumar S; Smith SO; Constantinescu SN
Mol Cell; 2003 Nov; 12(5):1239-50. PubMed ID: 14636581
[TBL] [Abstract][Full Text] [Related]
10. A potent erythropoietin-mimicking human antibody interacts through a novel binding site.
Liu Z; Stoll VS; Devries PJ; Jakob CG; Xie N; Simmer RL; Lacy SE; Egan DA; Harlan JE; Lesniewski RR; Reilly EB
Blood; 2007 Oct; 110(7):2408-13. PubMed ID: 17620453
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of signalling through cytokine receptors depends critically on receptor orientation.
Syed RS; Reid SW; Li C; Cheetham JC; Aoki KH; Liu B; Zhan H; Osslund TD; Chirino AJ; Zhang J; Finer-Moore J; Elliott S; Sitney K; Katz BA; Matthews DJ; Wendoloski JJ; Egrie J; Stroud RM
Nature; 1998 Oct; 395(6701):511-6. PubMed ID: 9774108
[TBL] [Abstract][Full Text] [Related]
12. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function.
Schimmenti LA; Blechert G; Harris KW; Winkelmann JC
Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements of the extracellular to transmembrane domain junction for erythropoietin receptor function.
Kubatzky KF; Liu W; Goldgraben K; Simmerling C; Smith SO; Constantinescu SN
J Biol Chem; 2005 Apr; 280(15):14844-54. PubMed ID: 15657048
[TBL] [Abstract][Full Text] [Related]
14. Identification of a critical ligand binding determinant of the human erythropoietin receptor. Evidence for common ligand binding motifs in the cytokine receptor family.
Middleton SA; Johnson DL; Jin R; McMahon FJ; Collins A; Tullai J; Gruninger RH; Jolliffe LK; Mulcahy LS
J Biol Chem; 1996 Jun; 271(24):14045-54. PubMed ID: 8662939
[TBL] [Abstract][Full Text] [Related]
15. Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor.
Kubatzky KF; Ruan W; Gurezka R; Cohen J; Ketteler R; Watowich SS; Neumann D; Langosch D; Klingmüller U
Curr Biol; 2001 Jan; 11(2):110-5. PubMed ID: 11231127
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin Receptor Structural Domains.
Li Q; Kang C
Vitam Horm; 2017; 105():1-17. PubMed ID: 28629512
[TBL] [Abstract][Full Text] [Related]
17. Conformational transitions upon ligand binding: holo-structure prediction from apo conformations.
Seeliger D; de Groot BL
PLoS Comput Biol; 2010 Jan; 6(1):e1000634. PubMed ID: 20066034
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the scissor-like mechanism of activation for the erythropoietin receptor.
Corbett MS; Poger D; Mark AE
FEBS Lett; 2016 Sep; 590(18):3083-8. PubMed ID: 27490140
[TBL] [Abstract][Full Text] [Related]
19. Physical and functional interaction between p72(syk) and erythropoietin receptor.
Duprez V; Blank U; Chrétien S; Gisselbrecht S; Mayeux P
J Biol Chem; 1998 Dec; 273(51):33985-90. PubMed ID: 9852052
[TBL] [Abstract][Full Text] [Related]
20. Structural mechanism of ligand activation in human GABA(B) receptor.
Geng Y; Bush M; Mosyak L; Wang F; Fan QR
Nature; 2013 Dec; 504(7479):254-9. PubMed ID: 24305054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
